This interesting finding was supported by our analysis on clinical cohort, in that HSP60 expression was found to be upregulated in Her2 positive breast cancer and such regulation was predicted to be affected by MAPK signalling [35]. This evidence concerns the gene ERBB2 and breast carcinoma.